ISL
CLB icon

Ingalls & Snyder LLC’s Core Laboratories CLB Stock Holding History

Ingalls & Snyder LLC’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,000
Closed -$124K – 473
2025
Q3 		$124K Hold
10,000
– – ﹤0.01% 464
2025
Q2 		$115K Buy
+10,000
New +$119K ﹤0.01% 448
2022
Q3 		– Sell
-10,000
Closed -$198K – 439
2022
Q2 		$198K Hold
10,000
– – 0.01% 410
2022
Q1 		$316K Buy
+10,000
New +$280K 0.01% 364
2018
Q4 		– Sell
-1,783
Closed -$207K – 418
2018
Q3 		$207K Hold
1,783
– – 0.01% 414
2018
Q2 		$225K Buy
+1,783
New +$217K 0.01% 362
2017
Q2 		– Sell
-3,248
Closed -$375K – 395
2017
Q1 		$375K Sell
3,248
-26
-0.8% -$3.02K 0.02% 285
2016
Q4 		$393K Sell
3,274
-34
-1% -$3.77K 0.02% 277
2016
Q3 		$372K Hold
3,308
– – 0.02% 280
2016
Q2 		$410K Buy
3,308
+187
+6% +$22.6K 0.02% 278
2016
Q1 		$350K Hold
3,121
– – 0.02% 262
2015
Q4 		$339K Hold
3,121
– – 0.02% 272
2015
Q3 		$311K Hold
3,121
– – 0.02% 279
2015
Q2 		$355K Sell
3,121
-187
-6% -$22.7K 0.02% 269
2015
Q1 		$345K Hold
3,308
– – 0.02% 272
2014
Q4 		$398K Hold
3,308
– – 0.02% 262
2014
Q3 		$484K Hold
3,308
– – 0.03% 242
2014
Q2 		$552K Sell
3,308
-7
-0.2% -$1.25K 0.03% 234
2014
Q1 		$657K Sell
3,315
-240
-7% -$45.3K 0.04% 213
2013
Q4 		$678K Sell
3,555
-6
-0.2% -$1.12K 0.04% 207
2013
Q3 		$602K Sell
3,561
-140
-4% -$21.7K 0.04% 216
2013
Q2 		$561K Buy
+3,701
New +$524K 0.04% 215

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Ingalls & Snyder LLC's CLB Position: Q4 2025 in Review

Ingalls & Snyder LLC sold out of Core Laboratories (CLB) in Q4 2025, closing a stake of 10,000 shares — an estimated $124K sold.

Ingalls & Snyder LLC first reported a position in CLB in Q2 2013 and held it in 22 quarters. The position peaked at $678K in Q4 2013. 187 funds tracked by Wall St. Rank hold CLB as of Q4 2025.

  • Ingalls & Snyder LLC reported no remaining Core Laboratories position as of Q4 2025 after selling out during the quarter.
  • Ingalls & Snyder LLC sold 10,000 Core Laboratories shares in Q4 2025, an estimated $124K.
  • Ingalls & Snyder LLC first reported a position in Core Laboratories in Q2 2013 and held it in 22 quarters.
  • Ingalls & Snyder LLC's Core Laboratories position peaked at $678K in Q4 2013.
  • 187 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2025.

Based on Ingalls & Snyder LLC's 13F filing for Q4 2025, filed 13 Feb 2026.